Coulie Bernard
- SEC CIK
- 0001808895
In the past year, 1 open-market sale filing worth $114.4K and no purchases.
Current role at each company
- SEPN Septerna, Inc.Directoras of Jun 30, 2026
- PLRX Pliant Therapeutics, Inc.President and CEOas of Apr 17, 2026
- SQZ SQZ Biotechnologies CoDirectoras of Jun 15, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $114.4K
- 1 filing
- Net
- −$114.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Coulie Bernard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PLRX Pliant Therapeutics, Inc.
President and CEO17 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2026 (view filing) | Jan 20 | 2 days | Coulie BernardPresident and CEO | SSale | −89.4K | $1.28 | −$114.4K | −15.0%505.6K after | 10b5-1 |
| Jan 22, 2025 (view filing) | Jan 17 | 5 days | Coulie BernardPresident and CEO | SSale | −52.4K | $11.20 | −$587.1K | −10.9%430.5K after | 10b5-1 |
| Jul 12, 2024 (view filing) | Jul 10 | 2 days | Coulie BernardPresident and CEO | SSale | −38.7K | $11.56 | −$447.5K | −7.4%482.9K after | 10b5-1 |
| Jan 19, 2024 (view filing) | Jan 17 | 2 days | Coulie BernardPresident and CEO | SSale | −25.7K | $17.23 | −$443.2K | −7.5%316.4K after | 10b5-1 |
| Jul 19, 2023 (view filing) | Jul 17 | 2 days | Coulie BernardPresident and CEO | SSale | −70.2K | $18.01 | −$1.26M | −17.0%342.1K after | 10b5-1 |
| Apr 3, 2023 (view filing) | Mar 30 | 4 days | Coulie BernardPresident and CEO | SSale | −35.3K | $26.52 | −$937.2K | −11.4%274.8K after | 10b5-1 |
| Feb 6, 2023 (view filing) | Feb 2-3 | 4 days | Coulie BernardPresident and CEO | SSale | −30.0K | $33.92 | −$1.02M | −11.1%240.1K after | 4 lots |
| Feb 1, 2023 (view filing) | Jan 30-Feb 1 | 2 days | Coulie BernardPresident and CEO | SSale | −45.0K | $34.48 | −$1.55M | −15.8%240.1K after | 6 lots |
| Jan 27, 2023 (view filing) | Jan 26-27 | 1 day | Coulie BernardPresident and CEO | SSale | −30.0K | $35.49 | −$1.06M | −11.1%240.1K after | 3 lots |
| Jan 27, 2023 (view filing) | Jan 26-27 | 1 day | Coulie BernardPresident and CEO | SSale | −25.0K | $35.11 | −$877.7K | −5.8%409.3K after | 3 lots |